Cargando…
P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430947/ http://dx.doi.org/10.1097/01.HS9.0000970456.81043.cc |
| _version_ | 1785091081874964480 |
|---|---|
| author | Chari, Ajai Diels, Joris Van Sanden, Suzy Pei, Lixia Ammann, Eric Heuck, Christoph Kane, Colleen Londhe, Anil Peterson, Steve Reece, Donna |
| author_facet | Chari, Ajai Diels, Joris Van Sanden, Suzy Pei, Lixia Ammann, Eric Heuck, Christoph Kane, Colleen Londhe, Anil Peterson, Steve Reece, Donna |
| author_sort | Chari, Ajai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430947 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309472023-08-17 P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA Chari, Ajai Diels, Joris Van Sanden, Suzy Pei, Lixia Ammann, Eric Heuck, Christoph Kane, Colleen Londhe, Anil Peterson, Steve Reece, Donna Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430947/ http://dx.doi.org/10.1097/01.HS9.0000970456.81043.cc Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Chari, Ajai Diels, Joris Van Sanden, Suzy Pei, Lixia Ammann, Eric Heuck, Christoph Kane, Colleen Londhe, Anil Peterson, Steve Reece, Donna P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title | P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full | P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_fullStr | P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full_unstemmed | P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_short | P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB VS SELINEXOR-DEXAMETHASONE AND VS BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_sort | p888: matched-adjusted indirect comparison of talquetamab vs selinexor-dexamethasone and vs belantamab mafodotin in patients with relapsed/refractory multiple myeloma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430947/ http://dx.doi.org/10.1097/01.HS9.0000970456.81043.cc |
| work_keys_str_mv | AT chariajai p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma AT dielsjoris p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma AT vansandensuzy p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma AT peilixia p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma AT ammanneric p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma AT heuckchristoph p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma AT kanecolleen p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma AT londheanil p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma AT petersonsteve p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma AT reecedonna p888matchedadjustedindirectcomparisonoftalquetamabvsselinexordexamethasoneandvsbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyeloma |